Head and Neck Neoplasm — Trials

Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 2,192 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06856213	Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.(ERBIOTAX)	recruiting	Phase 2	65	Grupo Español de Tratamiento de Tumores de Cabeza y CuelloOTHER	1	Jun 4, 2026	clinicaltrials
NCT07628062	Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation	not yet recruiting	Phase 2	70	ImmunityBio, Inc.